SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-046593
Filing Date
2020-08-13
Accepted
2020-08-13 16:13:38
Documents
1
Period of Report
2020-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7640
  Complete submission text file 0001209191-20-046593.txt   9073
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Issuer) CIK: 0000818686 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O BRIDGER MANAGEMENT, LLC. 90 PARK AVENUE, 40TH FL. NEW YORK NY 10016
Business Address
MIGNONE ROBERTO (Reporting) CIK: 0001258394 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-16174 | Film No.: 201099473